Daehwa Pharmaceutical logo

Daehwa Pharmaceutical

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Daehwa Pharmaceutical is a pharmaceutical company.

Investor Profile

Daehwa Pharmaceutical has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Daehwa Pharmaceutical frequently co-invest with?

Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
CSPC Pharmaceutical Group
Asia, Hebei, China, Shijiazhuang
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
CASVC
Asia, Beijing, China, Beijing
Co-Investments: 1
Atlas Capital LLC
North America, Arizona, United States, Phoenix
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Elite Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 1

What are some of recent deals done by Daehwa Pharmaceutical?

Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BFeb 11, 2019
Amount Raised: $146,600,000